BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 24018956)

  • 1. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
    Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
    Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
    Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
    J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma.
    Yang LP; Fu LC; Guo H; Xie LX
    Onkologie; 2012; 35(3):88-93. PubMed ID: 22414971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting recurrence in patients with Siewert type II carcinoma treated with curative resection.
    Fukuchi M; Mochiki E; Suzuki O; Ishiguro T; Sobajima J; Onozawa H; Imaizumi H; Shibata K; Saito K; Naitoh H; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2015 Jan; 35(1):505-9. PubMed ID: 25550595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
    Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
    Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.
    Mine S; Sano T; Hiki N; Yamada K; Kosuga T; Nunobe S; Yamaguchi T
    Br J Surg; 2013 Jul; 100(8):1050-4. PubMed ID: 23754647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.
    Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
    Anticancer Res; 2015 Jan; 35(1):445-56. PubMed ID: 25550586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
    Lee IS; Ahn JY; Yook JH; Kim BS
    World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
    Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.